Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ARIAD Pharmaceuticals ARIA

Healthcare Biotechnology
"ARIAD Pharmaceuticals Inc is an oncology company. The Company is engaged in transforming the lives of cancer patients with breakthrough medicines. It commercializes & develops products and product candidates including Iclusig, Brigatinib, and AP32788."

Recent & Breaking News (NDAQ:ARIA)

ARIAD to Present at the RBC Capital Markets Healthcare Conference

Business Wire February 19, 2014

Benchmark Indices Remain Flat as Nasdaq Jumps to Open Week of Trading

Equities.com February 18, 2014

Stocks Rally For Another Up Week on Wall Street

Equities.com February 14, 2014

TrendingWallStreet.com Begins Volume Coverage on ARIA, AZC, FSPM, and GM

Accesswire February 11, 2014

Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, LCI, NWSA and ONNN

Accesswire February 10, 2014

ARIAD to Host Conference Call and Webcast Discussion of Fourth Quarter and Year-End 2013 Financial Results on February 25, 2014

Business Wire February 10, 2014

TrendingWallStreet.com Announces Coverage on DDD, ARIA, ENIP, and LATF

Accesswire February 6, 2014

ARIAD to Present at the Leerink Swann Global Healthcare Conference

Business Wire February 5, 2014

ARIAD Announces Commercial Agreement for Iclusig (Ponatinib) in Australia

Business Wire January 28, 2014

Five Star Equities Issues New Research Reports on ARIA, CVM, NKTR and NTCT

Accesswire January 27, 2014

ARIAD Announces the Commercial Availability of Iclusig (Ponatinib) for Patients with Refractory Philadelphia-Positive Leukemias in the U.S.

Business Wire January 17, 2014

ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme(TM) Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease

Business Wire January 14, 2014

Biologics Selected by ARIAD to Be the Exclusive Specialty Pharmacy Provider for Iclusig (ponatinib)

Business Wire January 13, 2014

Notable Buzzers: Ariad Pharmaceuticals, Twitter Inc, Facebook Inc, Qihoo 360 Technology

Accesswire January 8, 2014

RDInvesting Provides Investors with Free In-Depth Equity Reports on ARIA, HOLX, VRTX and VTR

Accesswire January 7, 2014

Morning Buzzers: Apple Inc, Plug Power Inc, Ariad Pharmaceuticals, Biodel Inc

Accesswire January 3, 2014

ARIAD to Present at the 32nd Annual J.P. Morgan Healthcare Conference

Business Wire January 2, 2014

TrendingWallStreet.com Initiates Research on NOAH, SVFC, ARIA, and CNTO

Accesswire December 31, 2013

TrendingWallStreet.com Releases Volume Alerts on ARIA, MTOR, XXII, and TPCS

Accesswire December 24, 2013

Insider Catalyst Report: Ariad Pharmaceuticals, Advanced Micro Devices, Petroleo Brasileiro Petrobras, Endeavor IP Inc

Accesswire December 23, 2013